Sugi Predict

Sugi Predict / Compounds / SCHEMBL29494697

SCHEMBL29494697

SCHEMBL29494697

CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NTSR2 O95665 4/20 0.63
▸ NTSR1 P30989 4/20 0.63
▸ NPY1R P25929 1/20 0.56
▸ NPY2R P49146 1/20 0.56
▸ NPY4R P50391 1/20 0.56
▸ OPRK1 P41145 1/20 0.55
▸ F2 P00734 2/20 0.55
▸ SORT1 Q99523 3/20 0.54
▸ MDM4 O15151 1/20 0.54
▸ MDM2 Q00987 1/20 0.54
▸ CTSD P07339 3/20 0.54
▸ BACE1 P56817 5/20 0.53
▸ CDK4 P11802 1/20 0.52
▸ CCNA2 P20248 1/20 0.52
▸ CCND1 P24385 1/20 0.52
▸ CDK2 P24941 1/20 0.52
▸ BACE2 Q9Y5Z0 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29478299 0.97 NTSR2 (0.61) NTSR2NTSR1NPY1RNPY2RNPY4R
SCHEMBL29447812 0.96 NTSR2 (0.69) NTSR2NTSR1NPY1RNPY2RNPY4R
SCHEMBL29770017 0.94 NTSR2 (0.68) NTSR2NTSR1NPY1RNPY2RNPY4R
Kklfkkilkfl-Nh2 SCHEMBL29361484 0.94 NTSR2 (0.57) NTSR2NTSR1NPY1RNPY2RNPY4R
SCHEMBL29414490 0.92 BACE1 (0.64) NTSR2NTSR1F2MDM4MDM2
Kklfkkilkvl-Nh2 SCHEMBL30396617 0.92 NTSR2 (0.55) NTSR2NTSR1NPY1RNPY2RNPY4R
SCHEMBL29679986 0.91 NPY4R (0.62) NTSR2NTSR1NPY1RNPY2RNPY4R
SCHEMBL30423322 0.90 ACE (0.56) NTSR2NTSR1F2SORT1CTSD
SCHEMBL29473337 0.90 NTSR2 (0.56) NTSR2NTSR1NPY1RNPY2RNPY4R
SCHEMBL29473338 0.90 NTSR2 (0.56) NTSR2NTSR1NPY1RNPY2RNPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240409593-A1 COMPOSITION FOR SUPPRESSION OF INFLAMMATORY DISEASES COMPRISING BIOCOMPATIBLE POLYPEPTIDE TO WHICH FUNCTIONAL PEPTIDE IS CONJUGATED BIOVIT CO., LTD. (KR) 2024-12-12 — — US claimed
WO-2024123562-A2 PEPTIDE INHIBITORS OF BETA-LACTAMASE THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) 2024-06-13 — — WO claimed
WO-2024005225-A1 FILTER COATED WITH FUNCTIONAL POLYPEPTIDE 주식회사 바이오빛 2024-01-04 — — WO claimed
WO-2023229053-A1 COMPOSITION FOR PREVENTION OR TREATMENT OF CORONAVIRUS DISEASES 주식회사 바이오빛 2023-11-30 — — WO claimed
WO-2023187725-A1 TARGETED DELIVERY OF TRANSGENES IN PLANTS RELICA GENOMICS INC. (CA) 2023-10-05 — — WO claimed
WO-2022145518-A1 HARD COATING COMPOSITION COMPRISING ANTIBACTERIAL PROTEIN AND METHOD FOR PREPARING SAME 주식회사 바이오빛 2022-07-07 — — WO claimed
WO-2022114521-A1 COMPOSITION FOR SUPPRESSION OF INFLAMMATORY DISEASES COMPRISING BIOCOMPATIBLE POLYPEPTIDE TO WHICH FUNCTIONAL PEPTIDE IS CONJUGATED 주식회사 바이오빛 2022-06-02 — — WO claimed
WO-2026107246-A1 SELECTIVE SENOLYTIC CELL PENETRATING PEPTIDE COMPOSITIONS AND USES SENOTHERAPEUTIX, INC. (US) 2026-05-21 — — WO disclosed
EP-4731268-A1 CROSS-LINKED VESICLES WITH LOW-BOILING POINT FLUORINATED COMPOUND Bracco Suisse SA (CH) 2026-04-29 — — EP disclosed
US-20250382332-A1 NOVEL ALPHA-FACTOR BASED PEPTIDES WITH ANTIFUNGAL ACTIVITY INVAIO SCIENCES INC (US) 2025-12-18 — — US disclosed
US-20250381242-A1 ANTIMICROBIAL PEPTIDES AGAINST CITRUS GREENING INVAIO SCIENCES INC (US) 2025-12-18 — — US disclosed
EP-4655309-A2 PEPTIDE IN COMBINATION WITH FUNGICIDE COMPOSITIONS FOR FUNGAL CONTROL AND RELATED METHODS Flagship Pioneering Innovations VII, LLC (US) 2025-12-03 — — EP disclosed
US-12433845-B2 Peptide-functionalized biodegradable polymers for efficient delivery of various RNAs THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-10-07 — — US disclosed
WO-2022163978-A1 NOVEL ANTIMICROBIAL PEPTIDE WITH EXCELLENT MICROBIAL CYTOPLASM ELUTION EFFECT 주식회사 셀아이콘랩 2022-08-04 — — WO disclosed
WO-2022145518-A1 HARD COATING COMPOSITION COMPRISING ANTIBACTERIAL PROTEIN AND METHOD FOR PREPARING SAME 주식회사 바이오빛 2022-07-07 — — WO disclosed
US-20220183990-A1 PEPTIDE-FUNCTIONALIZED BIODEGRADABLE POLYMERS FOR EFFICIENT DELIVERY OF VARIOUS RNAS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2022-06-16 — — US disclosed
WO-2022114521-A1 COMPOSITION FOR SUPPRESSION OF INFLAMMATORY DISEASES COMPRISING BIOCOMPATIBLE POLYPEPTIDE TO WHICH FUNCTIONAL PEPTIDE IS CONJUGATED 주식회사 바이오빛 2022-06-02 — — WO disclosed
US-20220088131-A1 COMPOSITIONS AND METHODS RELATING TO C5L2 KING'S COLLEGE LONDON (GB) 2022-03-24 — — US disclosed
US-11279941-B2 Method for introducing protein into plant cell RIKEN (JP) 2022-03-22 — — US disclosed
WO-2022053456-A1 SPRAYABLE CELL-PENETRATING PEPTIDES FOR SUBSTANCE DELIVERY IN PLANTS BASF PLANT SCIENCE COMPANY GMBH (DE) 2022-03-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220183990-A1 PEPTIDE-FUNCTIONALIZED BIODEGRADABLE POLYMERS FOR EFFICIENT DELIVERY OF VARIOUS RNAS RNASE1, SNRPE, HNRNPAB NTSR2 1035/4885NTSR1 659/4885NPY1R 888/4885
US-12433845-B2 Peptide-functionalized biodegradable polymers for efficient delivery of various RNAs RNASE1, SNRPE, HNRNPAB NTSR2 1035/4885NTSR1 659/4885NPY1R 888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.